Moreover, CDKN1B mutations have also been functionally linked to the development of parathyroid tumors, thereby solidifying the role of aberrant cell cycle regulation in the development of parathyroid adenomas [64]. This evidence concerns the gene CDKN1B and parathyroid gland adenoma.